ArticleCancer immunology, immunotherapy : CII2025
FUBP3 mediates MXI1 stability to silence RRAS and hinder MAPK signaling in acute megakaryoblastic leukemia progression.
Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.